ATE426807T1 - Proteomanalyse verfahren zum drogen vergleich - Google Patents

Proteomanalyse verfahren zum drogen vergleich

Info

Publication number
ATE426807T1
ATE426807T1 AT01992891T AT01992891T ATE426807T1 AT E426807 T1 ATE426807 T1 AT E426807T1 AT 01992891 T AT01992891 T AT 01992891T AT 01992891 T AT01992891 T AT 01992891T AT E426807 T1 ATE426807 T1 AT E426807T1
Authority
AT
Austria
Prior art keywords
binding
proteom
analysis method
colloid
drug comparison
Prior art date
Application number
AT01992891T
Other languages
English (en)
Inventor
Cynthia Bamdad
R Bamdad
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Application granted granted Critical
Publication of ATE426807T1 publication Critical patent/ATE426807T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Materials Engineering (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Composite Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Colloid Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01992891T 2000-11-01 2001-11-01 Proteomanalyse verfahren zum drogen vergleich ATE426807T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24503500P 2000-11-01 2000-11-01

Publications (1)

Publication Number Publication Date
ATE426807T1 true ATE426807T1 (de) 2009-04-15

Family

ID=22925048

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01992891T ATE426807T1 (de) 2000-11-01 2001-11-01 Proteomanalyse verfahren zum drogen vergleich

Country Status (7)

Country Link
EP (1) EP1336104B1 (de)
JP (1) JP4335526B2 (de)
AT (1) ATE426807T1 (de)
AU (1) AU2002219971A1 (de)
CA (1) CA2426446C (de)
DE (1) DE60138130D1 (de)
WO (1) WO2002037109A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9657901A (en) 2000-10-03 2002-04-15 Minerva Biotechnologies Corp Magnetic in situ dilution
US7869013B2 (en) 2004-09-15 2011-01-11 Agency For Science, Technology And Research Surface plasmon resonance and quartz crystal microbalance sensor
JP5120588B2 (ja) * 2006-07-10 2013-01-16 独立行政法人科学技術振興機構 分子素子
JP5311406B2 (ja) * 2009-09-10 2013-10-09 独立行政法人産業技術総合研究所 免疫センサ
WO2011149525A1 (en) 2010-05-25 2011-12-01 Arryx, Inc. Holographic fluctuation microscopy apparatus and method for determining mobility of particle and/or cell dispersions
EP2788762B1 (de) * 2011-12-05 2018-08-15 The Trustees Of The University Of Pennsylvania Bioelektronische graphen-biomolekül-vorrichtungen
CN116075318A (zh) 2020-06-26 2023-05-05 米纳瓦生物技术公司 抗nme抗体及治疗癌症或癌症转移的方法
WO2023201234A2 (en) 2022-04-12 2023-10-19 Minerva Biotechnologies Corporation Anti-variable muc1* antibodies and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791069A (en) * 1984-09-21 1988-12-13 Ortho Diagnostic Systems Inc. Methods for attaching ligands or anti-ligands to a solid phase
US5620850A (en) 1994-09-26 1997-04-15 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
DE19802576B4 (de) * 1998-01-23 2004-10-28 Xerion Pharmaceuticals Ag Verfahren zur gleichzeitigen Identifizierung von Proteinen und ihren Bindungspartnern
EP1147416B1 (de) 1999-01-23 2013-05-29 Minerva Biotechnologies Corporation Assays unter verwendung von kolloiden sowie nicht-kolloidalen strukturen
AU3474100A (en) 1999-01-25 2000-08-07 Minerva Biotechnologies Corporation Rapid and sensitive detection of aberrant protein aggregation in neurodegenerative diseases
AU2001270157A1 (en) * 1999-01-25 2002-01-08 Minerva Biotechnologies Corporation Rapid and sensitive detection of protein aggregation
CN1185492C (zh) * 1999-03-15 2005-01-19 清华大学 可单点选通式微电磁单元阵列芯片、电磁生物芯片及应用
CA2369868A1 (en) * 1999-04-15 2000-10-26 The University Of Virginia Patent Foundation Proteome mining
JP2002542487A (ja) * 1999-04-15 2002-12-10 ザ、ボード、オブ、トラスティーズ、オブ、ザ、リーランド、スタンフォード、ジュニア、ユニバーシティ ポリペプチドのマイクロアレイ
WO2002001225A2 (en) * 2000-06-23 2002-01-03 Minerva Biotechnologies Corporation Tandem signaling assay
AU9657901A (en) * 2000-10-03 2002-04-15 Minerva Biotechnologies Corp Magnetic in situ dilution

Also Published As

Publication number Publication date
EP1336104B1 (de) 2009-03-25
WO2002037109A2 (en) 2002-05-10
JP4335526B2 (ja) 2009-09-30
AU2002219971A1 (en) 2002-05-15
DE60138130D1 (de) 2009-05-07
CA2426446C (en) 2015-07-14
JP2004532970A (ja) 2004-10-28
EP1336104A2 (de) 2003-08-20
CA2426446A1 (en) 2002-05-10
WO2002037109A3 (en) 2003-04-17

Similar Documents

Publication Publication Date Title
SE9504046D0 (sv) Method of determining affinity and kinetic properties
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
DE60019111D1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
DE60232688D1 (de) Grenzflächen-biomaterialien
DE50207516D1 (de) Verfahren zur herstellung von protein-beladenen mikropartikeln
DE69735127D1 (de) Enzymsensor
DE60143888D1 (de) Methode um die sensitivität einer luminesenz assay zu erhöhen
ATE179799T1 (de) Vorrichtung zur analyse von haptenen und ihre verwendung
EP1353181A4 (de) Biosensor und dessen verfahren zur analyse von blutbestandteilen
ATE426807T1 (de) Proteomanalyse verfahren zum drogen vergleich
DE69928507D1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ATE328276T1 (de) Verfahren zur identifizierung von liganden eines biologischen substrats
DE60202008D1 (de) Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten
ATE221657T1 (de) Entstörung durch rheumafaktoren
DE59813433D1 (de) Aufreinigung von substanzen aus einer biologischen probe
DE60226125D1 (de) Verfahren zur quantifizierung von glykiertem protein
SE0301058D0 (sv) Method and kit for cell analyte assay
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
EA199800843A1 (ru) Компьютерный способ создания химических структур, имеющих общие функциональные характеристики
SE0002835D0 (sv) Method and kit for production of monoclonal antibodies
ATE466884T1 (de) Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest
ZA9710964B (en) Synthetic biepitope compounds which can be used as standards in the biological assays of troponin I
ATE421093T1 (de) Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten
DK1181551T3 (da) Produkter og fremgangsmåder til enkeltparameter- og multiparameter-fænotypebestemmelse af celler

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1336104

Country of ref document: EP